Abvc Biopharma Stock Buy Hold or Sell Recommendation
| ABVC Stock | USD 1.48 0.13 9.63% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ABVC Biopharma is 'Sell'. Macroaxis provides ABVC Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABVC positions. The advice algorithm takes into account all of ABVC Biopharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting ABVC Biopharma's buy or sell advice are summarized below:
Real Value 1.58 | Target Price 2.02 | Hype Value 1.43 | Market Value 1.48 | Naive Value 1.35 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell ABVC Biopharma given historical horizon and risk tolerance towards ABVC Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for ABVC Biopharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
ABVC |
Execute ABVC Biopharma Buy or Sell Advice
The ABVC recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ABVC Biopharma. Macroaxis does not own or have any residual interests in ABVC Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ABVC Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Modest | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ABVC Biopharma Trading Alerts and Improvement Suggestions
| ABVC Biopharma had very high historical volatility over the last 90 days | |
| ABVC Biopharma may become a speculative penny stock | |
| ABVC Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 152.43 K. Net Loss for the year was (10.52 M) with profit before overhead, payroll, taxes, and interest of 350.71 K. | |
| ABVC Biopharma currently holds about 2.99 M in cash with (4.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
| ABVC Biopharma has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: ABVC BioPharma Engages the FreeMind Group to Support Grant Funding - The Globe and Mail |
ABVC Biopharma Returns Distribution Density
The distribution of ABVC Biopharma's historical returns is an attempt to chart the uncertainty of ABVC Biopharma's future price movements. The chart of the probability distribution of ABVC Biopharma daily returns describes the distribution of returns around its average expected value. We use ABVC Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ABVC Biopharma returns is essential to provide solid investment advice for ABVC Biopharma.
| Mean Return | 0.27 | Value At Risk | -6.25 | Potential Upside | 6.92 | Standard Deviation | 5.85 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ABVC Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ABVC Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ABVC Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ABVC Biopharma backward and forwards among themselves. ABVC Biopharma's institutional investor refers to the entity that pools money to purchase ABVC Biopharma's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Virtu Financial Llc | 2023-12-31 | 0.0 | Blackrock Inc | 2023-09-30 | 0.0 | Renaissance Technologies Corp | 2023-12-31 | 36.1 K | Vanguard Group Inc | 2023-12-31 | 27.2 K | Geode Capital Management, Llc | 2023-12-31 | 19.5 K | Citadel Advisors Llc | 2023-09-30 | 15.6 K | Tower Research Capital Llc | 2023-12-31 | 578 | Spotlight Asset Group, Inc. | 2023-12-31 | 100.0 | Royal Bank Of Canada | 2023-12-31 | 37.0 | Wells Fargo & Co | 2023-12-31 | 20.0 | Northern Trust Corp | 2023-09-30 | 0.0 |
ABVC Biopharma Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Free Cash Flow | (3.1M) | (4.6M) | (7.6M) | (7.5M) | (4.1M) | (3.9M) | |
| Other Non Cash Items | 204.3K | 2.2M | (91.1K) | 353.0K | 3.7M | 3.9M | |
| Net Income | (3.9M) | (10.6M) | (12.0M) | (16.3M) | (10.5M) | (10.0M) | |
| End Period Cash Flow | 160.4K | 5.0M | 6.6M | 1.4M | 716.8K | 875.2K | |
| Change To Inventory | 1.3K | (88.2K) | (25.8K) | 26.0K | 68.5K | 71.9K | |
| Change In Cash | (82.3K) | 4.8M | 1.6M | (5.2M) | (674.9K) | (641.2K) | |
| Depreciation | 55.1K | 37.1K | 12.0K | 23.8K | 28.5K | 24.1K | |
| Net Borrowings | 896.9K | 2.0M | 2.0M | (273.5K) | (314.5K) | (298.8K) | |
| Change To Netincome | 2.6M | (145.5K) | 5.3M | 6.8M | 7.9M | 8.3M | |
| Investments | (17.8K) | 147.8K | (806.0K) | (1.7M) | (360.2K) | (378.2K) |
ABVC Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ABVC Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ABVC Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ABVC stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.11 | |
β | Beta against NYSE Composite | 1.77 | |
σ | Overall volatility | 6.06 | |
Ir | Information ratio | 0.03 |
ABVC Biopharma Volatility Alert
ABVC Biopharma shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ABVC Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ABVC Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ABVC Biopharma Fundamentals Vs Peers
Comparing ABVC Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ABVC Biopharma's direct or indirect competition across all of the common fundamentals between ABVC Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as ABVC Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ABVC Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ABVC Biopharma to competition |
| Fundamentals | ABVC Biopharma | Peer Average |
| Return On Equity | -1.92 | -0.31 |
| Return On Asset | -0.43 | -0.14 |
| Operating Margin | (906.06) % | (5.51) % |
| Current Valuation | 13.01 M | 16.62 B |
| Shares Outstanding | 10.56 M | 571.82 M |
| Shares Owned By Insiders | 26.97 % | 10.09 % |
| Shares Owned By Institutions | 2.43 % | 39.21 % |
| Number Of Shares Shorted | 1.32 M | 4.71 M |
| Price To Book | 1.36 X | 9.51 X |
| Price To Sales | 75.52 X | 11.42 X |
| Revenue | 152.43 K | 9.43 B |
| Gross Profit | 350.71 K | 27.38 B |
| EBITDA | (8.19 M) | 3.9 B |
| Net Income | (10.52 M) | 570.98 M |
| Cash And Equivalents | 2.99 M | 2.7 B |
| Cash Per Share | 0.09 X | 5.01 X |
| Total Debt | 2.45 M | 5.32 B |
| Debt To Equity | 0.34 % | 48.70 % |
| Current Ratio | 2.68 X | 2.16 X |
| Book Value Per Share | 1.06 X | 1.93 K |
| Cash Flow From Operations | (4.06 M) | 971.22 M |
| Short Ratio | 0.92 X | 4.00 X |
| Earnings Per Share | (2.43) X | 3.12 X |
| Target Price | 2.02 | |
| Number Of Employees | 16 | 18.84 K |
| Beta | 0.77 | -0.15 |
| Market Capitalization | 14.26 M | 19.03 B |
| Total Asset | 14.94 M | 29.47 B |
| Retained Earnings | (65.42 M) | 9.33 B |
| Working Capital | (4.28 M) | 1.48 B |
| Net Asset | 14.94 M |
Note: Discretionary transaction by Jiang Shuling of tradable shares of ABVC Biopharma subject to Rule 16b-3 [view details]
ABVC Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ABVC . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ABVC Biopharma Buy or Sell Advice
When is the right time to buy or sell ABVC Biopharma? Buying financial instruments such as ABVC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 3.1M | 3.1M | 2.5M | 1.9M | Total Assets | 13.7M | 9.9M | 14.9M | 15.7M |
Use Investing Ideas to Build Portfolios
In addition to having ABVC Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hedge Favorites Thematic Idea Now
Hedge Favorites
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ABVC Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is ABVC Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.43) | Revenue Per Share 0.035 | Quarterly Revenue Growth (1.00) | Return On Assets (0.43) | Return On Equity (1.92) |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.